Clearstead Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57M | Sell |
3,520
-34
| -1% | -$15.1K | 0.02% | 358 |
|
|
2025
Q1 | $1.72M | Buy |
3,554
+117
| +3% | +$56.7K | 0.03% | 325 |
|
|
2024
Q4 | $1.38M | Sell |
3,437
-119
| -3% | -$47.9K | 0.02% | 354 |
|
|
2024
Q3 | $1.65M | Buy |
3,556
+1
| +0% | +$465 | 0.03% | 330 |
|
|
2024
Q2 | $1.67M | Buy |
3,555
+2,928
| +467% | +$1.37M | 0.03% | 302 |
|
|
2024
Q1 | $270K | Buy |
627
+146
| +30% | +$62.8K | 0.01% | 416 |
|
|
2023
Q4 | $196K | Sell |
481
-91
| -16% | -$37K | 0.01% | 456 |
|
|
2023
Q3 | $199K | Buy |
572
+307
| +116% | +$107K | 0.01% | 571 |
|
|
2023
Q2 | $93.3K | Sell |
265
-6
| -2% | -$2.11K | 0.01% | 595 |
|
|
2023
Q1 | $85.4K | Sell |
271
-218
| -45% | -$68.7K | 0.01% | 537 |
|
|
2022
Q4 | $141K | Hold |
489
| – | – | 0.01% | 428 |
|
|
2022
Q3 | $142K | Buy |
489
+485
| +12,125% | +$141K | 0.01% | 411 |
|
|
2022
Q2 | $1K | Hold |
4
| – | – | ﹤0.01% | 1235 |
|
|
2022
Q1 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 1332 |
|
|
2021
Q2 | – | Sell |
-158
| Closed | -$34K | – | 1306 |
|
|
2021
Q1 | $34K | Buy |
+158
| New | +$34K | ﹤0.01% | 590 |
|
|
2020
Q2 | – | Sell |
-20
| Closed | -$5K | – | 839 |
|
|
2020
Q1 | $5K | Buy |
+20
| New | +$5K | ﹤0.01% | 656 |
|